Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Germapharm GmbH is a specialized German pharmaceutical company and a core subsidiary of the Aristo Pharma Group, focusing on the hygiene and infection prevention sectors. Based in Moosburg, the company is a leading manufacturer of medical-grade disinfectants, antiseptics, and specialized hygiene products for clinical and retail markets. Germapharm operates as a key production hub within the Aristo network, utilizing advanced facilities for the manufacture of liquid and semi-solid pharmaceutical forms. In addition to its own product portfolio, the company provides comprehensive contract manufacturing (CMO) services, including formulation development and aseptic filling. Germapharm is ultimately owned by the Strüngmann family, prominent investors in the global biotechnology industry, and plays a critical role in the European healthcare supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Germapharm.